Replies to post #19275 on Anavex Life Sciences Corp (AVXL)

[GrowthStockInvestor]

ONVO uplisted without RS, SLTD did an RS before uplisting, I was in both... AVXL, with good news, I believe could get above $4 without RS... It would all depend on how well Phase 2A is doing. If Missling announces significant results we could meet NYSE listing requirements quickly.

[InforichIH]

Recent price action in ADXS is another example of rapid price rise to a broker's target after an RS, then a plunge to wipe out recent retail buyers. Big money can hedge positions and cause big adverse moves for longs.